Panel & Audience Discussion: Collaborative Strategies for Advancing Antifibrotic Drug Development Across Diverse Disease Indications
Time: 5:00 pm
day: Day One
Details:
This panel discussion gathers experts from across the various disease indications to discuss what is needed to collectively advance antifibrotic drug development across the broad spectrum of diseases.
Expect coverage of:
- With an increase recognition of the complexity and heterogeneity of fibrotic diseases, will combination therapies be necessary to secure clinical efficacy above the current standards of care?
- What is the true bottleneck halting progression of antifibrotic therapeutics through the clinical and to patients?
- Do we need to focus on detecting higher risk patients for earlier diagnosis and earlier intervention to prevent late-stage fibrosis?
- Where should we be directing future research efforts?
